gb5005 cart
Chimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen UniversityCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Chimeric Antigen Receptor T-cell cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Universal Cll1 Car-T Cells Mingfeng Zhao | Phase 1 | CC |
Same molecule, other indications
gb5005 cart is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →